Converge Bio raises $25 million for drug discovery
Converge Bio raised $25 million in its latest funding round. Bessemer Venture Partners led the investment. Several top leaders from Meta and OpenAI also joined in.
The company uses artificial intelligence to find new drugs faster. Their goal is to make the process of creating medicine more accurate. They want to cut down the time it takes to get treatments to patients.
This cash will help the team grow their staff. They also plan to improve their technology. It is a big step for a young company in the medical field.
Comments (0)
No comments yet. Be the first!
More AI news
NewsNew AI Tool Fixes Mistakes in Financial Research
Researchers developed a new framework to stop AI from learning from its own bad data in financial trading models.
NewsPerplexity adds local AI to Mac apps
The new update lets your Mac handle some AI tasks directly on your computer.
NewsMeta Releases Muse Image Model on Fal
Meta has launched a new AI model on the Fal platform that plans and edits images on its own.